UCLA study could be step toward a treatment for limb girdle muscular dystrophy
Researchers from the Center for Algorithmic Biotechnology at St Petersburg University, as part of a group of Russian and American scientists, have developed the metaFlye assembler. It is designed to assemble DNA samples from microbial communities. With its help, it is possible to solve a wide range of fundamental and applied problems, among which is the control of the process of treating patients and even the creation of new drugs. A paper about the assembler is published in the peer-reviewed academic journal Nature Methods.
A team led by Weill Cornell Medicine scientists has pioneered a method for manufacturing functioning human blood vessels and demonstrated that they can carry blood in lab-grown model organs and tumors. The discovery will enable disease modeling, and may facilitate the future production of human transplantable organs and identification of new precision drugs to treat cancer.
Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be implicated. A particular protein triggers a part of our immune system that can boost the blood’s tendency to coagulate and form clots. The study is now published in Thrombosis and Haemostasis.
Materials scientists from Nanyang Technological University, Singapore (NTU Singapore) have invented a new type of surgical glue that can help join blood vessels and close wounds faster and may also serve as a platform to deliver pain relief drugs.